Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial.The Lancet Diabetes & Endocrinology 2020;8:392406
In future, we plan to use the RNAi (RNA interference) method both at the cellular and animal levels to further investigate in-depth about the mechanism, especially the network between ER stress and the NO system
doi: 10.1111/j.1365-2796.1994.tb00802.x
Generally, the guidelines we follow are: Acute conditions: Treatments may be administered as frequently as daily or multiple times per week
By enhancing detoxification, you can optimize glutathione function
Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft